公开(公告)号：US10300283B2

公开(公告)日：2019-05-28

申请号：US14247923

申请日：2014-04-08

Applicant: Medtronic, Inc.

Inventor： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

IPC: A61N1/36 ,  A61B5/0205 ,  A61B5/11 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  A61B3/113 ,  A61B5/0476 ,  A61B5/08 ,  A61B5/145 ,  A61N1/365 ,  A61N1/372

Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.

公开(公告)号：US20140222101A1

公开(公告)日：2014-08-07

申请号：US14247923

申请日：2014-04-08

Applicant: Medtronic, Inc.

Inventor： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

IPC: A61N1/36

CPC classification number: A61N1/36135 ,  A61B3/113 ,  A61B5/0031 ,  A61B5/0205 ,  A61B5/0476 ,  A61B5/0816 ,  A61B5/1116 ,  A61B5/1118 ,  A61B5/145 ,  A61B5/4815 ,  A61B5/4818 ,  A61B5/6814 ,  A61B5/6823 ,  A61B5/6825 ,  A61B5/686 ,  A61B2562/0219 ,  A61M5/14276 ,  A61M5/1723 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36067 ,  A61N1/36071 ,  A61N1/36082 ,  A61N1/36521 ,  A61N1/36542 ,  A61N1/36557 ,  A61N1/37247

Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.

Abstract translation: 设备基于感测到的生理参数值来确定指示患者睡眠质量的一个或多个度量的值。 睡眠效率，睡眠延迟和在更深的睡眠状态中花费的时间是可以确定值的示例性睡眠质量度量。 例如，可以使用睡眠质量度量值来评估由医疗装置递送给患者的治疗的有效性。 在一些实施例中，确定的睡眠质量量度值与治疗参数组自动相关联，当感测到生理参数值时医疗设备根据该参数设置递送治疗，并且用于评估各种治疗参数组的有效性。 医疗装置可以递送治疗以治疗非呼吸神经障碍，例如癫痫，运动障碍或心理障碍。 治疗可以是例如深部脑刺激（DBS）治疗。

公开(公告)号：US20190217098A1

公开(公告)日：2019-07-18

申请号：US16365731

申请日：2019-03-27

Applicant: Medtronic, Inc.

Inventor： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

IPC: A61N1/36 ,  A61M5/172 ,  A61B5/00 ,  A61B5/11 ,  A61M5/142 ,  A61B5/0205

CPC classification number: A61N1/36135 ,  A61B3/113 ,  A61B5/0031 ,  A61B5/0205 ,  A61B5/0476 ,  A61B5/0816 ,  A61B5/1116 ,  A61B5/1118 ,  A61B5/145 ,  A61B5/4815 ,  A61B5/4818 ,  A61B5/6814 ,  A61B5/6823 ,  A61B5/6825 ,  A61B5/686 ,  A61B2562/0219 ,  A61M5/14276 ,  A61M5/1723 ,  A61N1/36025 ,  A61N1/36064 ,  A61N1/36067 ,  A61N1/36071 ,  A61N1/36082 ,  A61N1/36521 ,  A61N1/36542 ,  A61N1/36557 ,  A61N1/37247

Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.

公开(公告)号：US11096591B2

公开(公告)日：2021-08-24

申请号：US16365731

申请日：2019-03-27

Applicant: Medtronic, Inc.

Inventor： Keith A. Miesel ,  Kenneth T. Heruth ,  Jonathan C. Werder ,  Steve R. LaPorte ,  Nina M. Graves

IPC: A61N1/36 ,  A61M5/172 ,  A61B5/00 ,  A61B5/11 ,  A61M5/142 ,  A61B5/0205 ,  A61B3/113 ,  A61B5/08 ,  A61B5/145 ,  A61N1/365 ,  A61N1/372 ,  A61B5/369

Abstract: A device determines values for one or more metrics that indicate the quality of a patient's sleep based on sensed physiological parameter values. Sleep efficiency, sleep latency, and time spent in deeper sleep states are example sleep quality metrics for which values may be determined. The sleep quality metric values may be used, for example, to evaluate the effectiveness of a therapy delivered to the patient by a medical device. In some embodiments, determined sleep quality metric values are automatically associated with the therapy parameter sets according to which the medical device delivered the therapy when the physiological parameter values were sensed, and used to evaluate the effectiveness of the various therapy parameter sets. The medical device may deliver the therapy to treat a non-respiratory neurological disorder, such as epilepsy, a movement disorder, or a psychological disorder. The therapy may be, for example, deep brain stimulation (DBS) therapy.